Delivery Order SPE2DB22D1202-SPE2DB23FHKU7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the delivery of Emgality 120 mg/ml pen injectors. The contract is a Firm Fixed Price Delivery Order that runs through March 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Emgality 120 mg/mL pen injector. The fixed-price delivery order, valued at $1,713.20, has an ultimate completion date of April 15, 2025. This contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,377.66, is for the delivery of the prescription drug Emgality 120 mg/ml penml. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,179.64 firm-fixed-price contract is for the supply of Emgality 120 mg/ml pens, a prescription medication. The contract has a period of performance through September 12, 2024. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,208.26 firm fixed-price contract is for the supply of the pharmaceutical product Emgality 120 mg/ml pen. The contract has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729, is a delivery order for the drug Emgality 120 mg/ml pen. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Emgality 120 mg/ml pens. The contract has a ceiling value of $1,002.72 and runs through August 5, 2024. AmerisourceBergen provides a wide range of pharmaceutical and medical products to various government agencies and healthcare programs, including the military and veterans' hospitals. The company holds several...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/ml pens, a medication used for the treatment of migraines. The contract has a ceiling value of $1,124.81 and runs through February 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,063.82, is for the delivery of Emgality 120 mg/ml Penml, a medication, on a firm fixed price basis. The contract has an ultimate completion date of June 26, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHKU7Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,739.03, is for the supply of Emgality 120 mg/ml pen injectors. It is a firm fixed-price contract with an ultimate completion date of April 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/12/23 |